62 related articles for article (PubMed ID: 7999083)
1. Effect of thyrotropin and adenosine on inositol phospholipids pathway in human thyroid in Graves' disease.
Zarzycki W; Mośko P; Jaroszewicz L; Kinalska I
Biochem Biophys Res Commun; 1994 Nov; 205(1):584-9. PubMed ID: 7999083
[TBL] [Abstract][Full Text] [Related]
2. Effect of thyrotropin on inositol phospholipids pathway in human thyroid non-toxic goitre.
Mosko P; Zarzycki W; Jaroszewicz L; Kinalska I
Biochem Biophys Res Commun; 1994 Jun; 201(3):1182-8. PubMed ID: 8024560
[TBL] [Abstract][Full Text] [Related]
3. In vitro demonstration of normal thyrotropin (TSH) responsiveness in thyroid tissue from patients with Graves' disease.
Field JB; Larsen PR; Yamashita K
Trans Assoc Am Physicians; 1973; 86():300-9. PubMed ID: 4363386
[No Abstract] [Full Text] [Related]
4. TSH stimulation of 32P incorporation into phospholipids of thyroids from patients with Graves' disease.
Schneider PB
J Clin Endocrinol Metab; 1974 Jan; 38(1):148-50. PubMed ID: 4358643
[No Abstract] [Full Text] [Related]
5. Stimulation of arachidonic acid release from thyroid phospholipids.
Stelmach H; Jaroszewicz L
J Physiol Pharmacol; 1995 Dec; 46(4):439-46. PubMed ID: 8770788
[TBL] [Abstract][Full Text] [Related]
6. Proceedings: Influence of human thyroid-stimulating hormone and immunoglobulins from patients with Graves' disease on human thyroid cyclic AMP.
Holmes SD; Dirmikis SM; Martin TJ; Munro DS
J Endocrinol; 1976 Jun; 69(3):8P-9P. PubMed ID: 181521
[No Abstract] [Full Text] [Related]
7. Adenosine 3',5'-monophosphate concentrations and responsiveness to thyrotropin and thyroid-stimulating immunoglobulins in normal and Graves' thyroids.
Kuzuya N; Uchimura H; Ikeda H; Chiu SC; Hamada N; Ito K; Nagataki S
J Clin Endocrinol Metab; 1980 Jul; 51(1):59-63. PubMed ID: 6247365
[No Abstract] [Full Text] [Related]
8. Effect of TSH on the 24-hr 131-I uptake in Graves' disease.
Charkes ND
J Nucl Med; 1969 May; 10(5):246-8. PubMed ID: 4181519
[No Abstract] [Full Text] [Related]
9. Effects of biogenic amines on the formation of adenosine 3',5'-monophosphate in human thyroid slices.
Sato A; Hashizume K; Onaya T; Miyakawa M; Makiuchi M
Endocrinol Jpn; 1977 Aug; 23(4):319-25. PubMed ID: 200414
[TBL] [Abstract][Full Text] [Related]
10. Effect of TSH on iodine metabolism and intermediary metabolism in tissue from patients with Graves' disease.
Field JB; Larsen PR; Yamashita K; Chayoth R
J Clin Endocrinol Metab; 1974 Nov; 39(5):942-9. PubMed ID: 4370784
[No Abstract] [Full Text] [Related]
11. Phospholipids of human thyroid gland.
Stelmach H; Mośko P; Jaroszewicz L; Piotrowski Z; Puchalski Z
Acta Physiol Hung; 1993; 81(3):263-7. PubMed ID: 8197881
[TBL] [Abstract][Full Text] [Related]
12. Alterations of adrenergic systems in thyroid slices from patients with Graves' disease.
Yamashita K; Aiyoshi Y; Kuzuya N; Koide Y
Acta Endocrinol (Copenh); 1985 Nov; 110(3):360-5. PubMed ID: 2866653
[TBL] [Abstract][Full Text] [Related]
13. Expression of thioredoxin in patients with Graves' disease.
Kihara M; Kontani K; Yamauchi A; Miyauchi A; Nakamura H; Yodoi J; Yokomise H
Int J Mol Med; 2005 May; 15(5):795-9. PubMed ID: 15806300
[TBL] [Abstract][Full Text] [Related]
14. TSH receptor protein is selectively expressed in normal human extraocular muscle.
Kloprogge SJ; Busuttil BE; Frauman AG
Muscle Nerve; 2005 Jul; 32(1):95-8. PubMed ID: 15779008
[TBL] [Abstract][Full Text] [Related]
15. Induction of stimulating thyrotropin receptor antibodies after radioiodine therapy for toxic multinodular goitre and Graves' disease measured with a novel bioassay.
Hovens GC; Heemstra KA; Buiting AM; Stokkel MP; Karperien M; Ballieux BE; Pereira AM; Romijn JA; Smit JW
Nucl Med Commun; 2007 Feb; 28(2):123-7. PubMed ID: 17198353
[TBL] [Abstract][Full Text] [Related]
16. The adenylate cyclase-cyclic AMP system in Graves' disease.
Field JB; Muto H; Chou MC
Adv Cyclic Nucleotide Res; 1980; 12():359-72. PubMed ID: 6250367
[No Abstract] [Full Text] [Related]
17. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease.
Takasu N; Kamijo K; Sato Y; Yoshimura H; Nagata A; Ochi Y
Clin Exp Pharmacol Physiol; 2004; 31(5-6):314-9. PubMed ID: 15191404
[TBL] [Abstract][Full Text] [Related]
18. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
[TBL] [Abstract][Full Text] [Related]
19. [Immunopathology of Graves'-Basedow disease].
Baj Z; Ferenc T; Lewiński A
Postepy Hig Med Dosw; 1997; 51(5):531-46. PubMed ID: 9489453
[TBL] [Abstract][Full Text] [Related]
20. The metabolism of phosphatidylinositol in the thyroid gland of the pig.
Jungalwala FB; Freinkel N; Dawson RM
Biochem J; 1971 Jun; 123(1):19-33. PubMed ID: 4331518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
